We serve Chemical Name:3-Bromo-6-methyl-1H-indazole CAS:40598-73-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Bromo-6-methyl-1H-indazole
CAS.NO:40598-73-0
Synonyms:3-Bromo-6-methyl-1H-indazole;1H-Indazole,3-bromo-6-methyl;3-BROMO-6-METHYL-INDAZOLE;INDAZOLE,3-BROMO-6-METHYL;1H-Indazole, 3-bromo-6-methyl-
Molecular Formula:C8H7BrN2
Molecular Weight:211.059
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:345.0±22.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.697
PSA:28.68000
Exact Mass:209.979248
LogP:3.35
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Bromo-6-methyl-1H-indazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Indazole, 3-bromo-6-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Bromo-6-methyl-1H-indazole Use and application,1H-Indazole, 3-bromo-6-methyl- technical grade,usp/ep/jp grade.
Related News: CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. RNA (human enterovirus 71 isolate 7673-CT-87 gene VP1 fragment) manufacturers Orchard’s decision is suggestive of the difficulty drugmakers can face in turning complex, but promising rare disease treatments into a sustainable business. The termination wasn’t unexpected; Orchard said last May it was reducing staff and reordering its priorities, reducing investment in OTL-101 as a result. 2-fluoro-3,N-dimethoxy-N-methyl-benzamide suppliers Dr. Elsie Melsopp, Head of Solids Formulations for Alcami, says the company successfully helped a client overcome an API supply shortage using Quality by Design (QbD) studies to successfully formulate an orphan drug product. tert-Butyl-dimethyl-[2,3,5,6-tetramethyl-4-(4-nitro-benzenesulfinyl)-phenoxy]-silane vendor & factory.
